Needs - Your Resource for Health and Wellness
Call Toll Free: 1.800.634.1380
Facebook
Blog
Twitter
Twitter
Twitter
spacer
Listen and Learn
Teleseminar Speaker Laurel Sterling, MA, RDN, CDN,
spacer
About TransFirst®
Card Acceptance
Shipping
Doctor's Best Authorized Online Retailer


The New Gold Standard for Menopausal Relief
Submitted by Metagenics

Estrovera is a natural option that features ERr 731, a special extract of Siberian rhubarb, demonstrated in clinical studies to significantly reduce menopausal symptoms—offering an effective and safer option for both peri- and postmenopausal women.*

Effective Relief for Menopausal Symptoms*
Clinically shown to dramatically reduce the number of daily hot flashes and relieve a wide range of other symptoms.*

Efficacy Comparable to Hormone Therapies*
Demonstrated to relieve hot flashes to a similar extent as estrogen-based therapies and exceed reported results of other phytoestrogen and botanical approaches.*

Unprecedented Scientific Validation for a Phytoestrogen Approach*
Multiple short- and long-term studies with over 400 peri- and postmenopausal women— published in peer-reviewed journals—confirm efficacy and predicted safety*. For example:

  • In a 12-week clinical study with ERr 731, perimenopausal women reported significant improvements in symptoms—including hot flashes and anxiety—within just 28 days (compared to placebo)*3,4

  • In another 12-week clinical study, ERr 731 reduced average number of daily hot flashes from 12 to 2*5

  • In a six-month study, ERr 731 demonstrated progressive relief of multiple symptoms measured by the Menopause Rating Scale (MRS), including:*1

    • Negative mood, irritability & anxiety

    • Joint and muscle discomfort

    • Physical/mental exhaustion

    • Sleep disturbances

    • Hot flashes/night sweats
  • In a two-year study with ERr 731, ~83% reduction of the total MRS II score was maintained from 60 weeks to 108 weeks*2

  • Estrovera provides a clinically effective dose of ERr 731 in just 1 tablet daily*


  • Excellent Safety Profile*
    ERr 731 has been professionally recommended for over 20 years with no serious adverse events reported and no clinically relevant changes in safety parameters have been observed in clinical trials.*

    References
    1. Altern Ther Health Med. 2008;14(6):32-38.
    2. Menopause. 2009;16(1):117-131.
    3. Menopause. 2006;13(5):744-759.
    4. Menopause. 2007;14(2):270-283.
    5. Altern Ther Health Med. 2009;15(1):24-34.


    *This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.




    Related Products
    Protective Breast Formula
    AM/PM Menopause Formula
    Female Support
    Estrovera